返回 Agenda
Session Chair(s)
Lollo Eriksson, DrMed
United States
Learning Objective : -Key activities identified by companies that comprise the site initiation process -The challenges companies face in initiating studies and what resources or processes would speed study initiation -Cycle time metrics and variation across phases of research and therapeutic area
Speaker(s)
Benchmarking the clinical trial site initiation process
Mary Jo Lamberti, PHD, MA
Tufts Center for the Study of Drug Development, United States
Director of Sponsored Research, Research Associate Professor
Pharmaceutical R&D Process- Why do clinical trials fail?
Erika Buonansegna, MSC
Technical University of Denmark, Denmark
PhD Student
Reasons for project discontinuation in the pharmaceutical industry
Jorge Mestre-Ferrandiz, PHD
Office of Health Economics, United Kingdom
Director of Consulting